Evaluating a Digital Intervention for Overactive Bladder
Primary Purpose
Overactive Bladder
Status
Completed
Phase
Not Applicable
Locations
Ireland
Study Type
Interventional
Intervention
NUIG OAB App
Sponsored by
About this trial
This is an interventional treatment trial for Overactive Bladder
Eligibility Criteria
Inclusion Criteria:
- On waiting list for Urogynaecologist at participating hospital
- Referred for Overactive bladder from GP
- Symptoms of Overactive bladder to include at least one of the following: urgency of urination, frequency of urination or urge incontinence.
- Female
- 18 years or older
- Own a smartphone
Exclusion Criteria:
- Active/Recurrent urinary tract infection
- Urinary retention
- Bladder Pain Syndrome/ interstitial cystitis
- Pelvic/gynae cancer
- Pregnant
- Dementia
- Kidney problems
- Stroke
- Have/had a neuro-stimulation implant for treatment of OAB
Sites / Locations
- The Rotunda Hospital
- The National Maternity Hospital
- Galway University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
NUIG OAB App
Arm Description
Digital behaviour change intervention. Software-delivered intervention including best-practice behavioural therapy, and evidence-based dietetics, physiotherapy and psychology treatments to reduce the symptoms of overactive bladder.
Outcomes
Primary Outcome Measures
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module (ICIQ-OABqol)
Change from baseline patient-reported overactive bladder related quality of life at week 8. Minimum score 25, maximum score 160. Greater values indicating increased impact on quality of life
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)
Change from baseline patient-reported overactive bladder symptoms at week 8. Minimum score 0, maximum score 16. Greater values indicate increased symptom severity.
Change in Digital Bladder Diary frequency of urination
Change from baseline frequency of urination at week 8.
Frequency of urination measured in-app, in real-time as number of urinations per day logged by user for 3 days at baseline and 3 days in week 8.
Secondary Outcome Measures
Programme adherence
Total number of seconds spent on app from day 1 of week 1 to day 7 of week 8. Total number of times app accessed between day 1 of week 1 and day 7 of week 8. Total number of in-app 'challenges' completed throughout the 8 week intervention.
Mobile Applications Rating Scale, user version (MARSu)
User reported ratings of app quality based on Engagement, Functionality, Aesthetics, and Information. Minimum score 20, maximum score 100. Greater values indicate higher app quality.
Patient Global impression of improvement
One item questionnaire with Likert scale of 1 to 7. Greater values indicate disimproved condion.
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module (ICIQ-OABqol)
Change from baseline patient-reported overactive bladder related quality of life at week 4. Minimum score 25, maximum score 160. Greater values indicate increased impact on quality of life.
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)
Change from baseline patient-reported overactive bladder symptoms at week 4. Minimum score 0, maximum score 16. Greater values indicate increased symptom severity.
Full Information
NCT ID
NCT05170100
First Posted
October 29, 2021
Last Updated
December 10, 2021
Sponsor
National University of Ireland, Galway, Ireland
Collaborators
Enterprise Ireland
1. Study Identification
Unique Protocol Identification Number
NCT05170100
Brief Title
Evaluating a Digital Intervention for Overactive Bladder
Official Title
Evaluating a Digital Intervention for Overactive Bladder: Protocol for a Single-arm, Multisite Pilot Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2021
Overall Recruitment Status
Completed
Study Start Date
September 1, 2021 (Actual)
Primary Completion Date
November 7, 2021 (Actual)
Study Completion Date
November 7, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
National University of Ireland, Galway, Ireland
Collaborators
Enterprise Ireland
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Overactive Bladder is characterised by (I) Urgency: the sudden and compelling desire to pass urine with or without accidental leakage; (II) Frequency: the need to pass urine far more regularly than is considered normal; and (III) Nocturia: the need to pass urine several times during the night. This study aims to investigate the feasibility, acceptability and preliminary efficacy of a digital intervention (the NUIG OAB App) for overactive bladder. Furthermore, this study will help determine the most appropriate outcomes for use in the future definitive RCT and the effect size for future sample size calculations. Participants will complete an 8-week intervention designed to reduce the symptoms of OAB, delivered through the NUIG OAB App. Participants will be asked to complete online surveys at baseline, 4 weeks and 8 weeks and an in-app Bladder Diary at weeks 1 and 8. There will be no in-person contact with participants by the study team.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Overactive Bladder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
29 (Actual)
8. Arms, Groups, and Interventions
Arm Title
NUIG OAB App
Arm Type
Experimental
Arm Description
Digital behaviour change intervention. Software-delivered intervention including best-practice behavioural therapy, and evidence-based dietetics, physiotherapy and psychology treatments to reduce the symptoms of overactive bladder.
Intervention Type
Behavioral
Intervention Name(s)
NUIG OAB App
Intervention Description
An interactive software-delivered 8-week intervention accessed through the patients' mobile device. It provides best-practice behavioural therapy, and delivers evidence-based dietetics, physiotherapy and psychology treatments to reduce the symptoms of overactive bladder.
Primary Outcome Measure Information:
Title
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module (ICIQ-OABqol)
Description
Change from baseline patient-reported overactive bladder related quality of life at week 8. Minimum score 25, maximum score 160. Greater values indicating increased impact on quality of life
Time Frame
baseline and week 8
Title
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)
Description
Change from baseline patient-reported overactive bladder symptoms at week 8. Minimum score 0, maximum score 16. Greater values indicate increased symptom severity.
Time Frame
baseline and week 8
Title
Change in Digital Bladder Diary frequency of urination
Description
Change from baseline frequency of urination at week 8.
Frequency of urination measured in-app, in real-time as number of urinations per day logged by user for 3 days at baseline and 3 days in week 8.
Time Frame
baseline & week 8
Secondary Outcome Measure Information:
Title
Programme adherence
Description
Total number of seconds spent on app from day 1 of week 1 to day 7 of week 8. Total number of times app accessed between day 1 of week 1 and day 7 of week 8. Total number of in-app 'challenges' completed throughout the 8 week intervention.
Time Frame
data collected throughout the 8 week intervention.
Title
Mobile Applications Rating Scale, user version (MARSu)
Description
User reported ratings of app quality based on Engagement, Functionality, Aesthetics, and Information. Minimum score 20, maximum score 100. Greater values indicate higher app quality.
Time Frame
week 4
Title
Patient Global impression of improvement
Description
One item questionnaire with Likert scale of 1 to 7. Greater values indicate disimproved condion.
Time Frame
week 8
Title
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module (ICIQ-OABqol)
Description
Change from baseline patient-reported overactive bladder related quality of life at week 4. Minimum score 25, maximum score 160. Greater values indicate increased impact on quality of life.
Time Frame
baseline and week 4
Title
Change in International Consultation on Incontinence Questionnaire Overactive Bladder Module (ICIQ-OAB)
Description
Change from baseline patient-reported overactive bladder symptoms at week 4. Minimum score 0, maximum score 16. Greater values indicate increased symptom severity.
Time Frame
baseline and week 4
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
On waiting list for Urogynaecologist at participating hospital
Referred for Overactive bladder from GP
Symptoms of Overactive bladder to include at least one of the following: urgency of urination, frequency of urination or urge incontinence.
Female
18 years or older
Own a smartphone
Exclusion Criteria:
Active/Recurrent urinary tract infection
Urinary retention
Bladder Pain Syndrome/ interstitial cystitis
Pelvic/gynae cancer
Pregnant
Dementia
Kidney problems
Stroke
Have/had a neuro-stimulation implant for treatment of OAB
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brendan Staunton
Organizational Affiliation
National University of Ireland, Galway
Official's Role
Principal Investigator
Facility Information:
Facility Name
The Rotunda Hospital
City
Dublin
ZIP/Postal Code
D01 P5W9
Country
Ireland
Facility Name
The National Maternity Hospital
City
Dublin
ZIP/Postal Code
D02 YH21
Country
Ireland
Facility Name
Galway University Hospital
City
Galway
ZIP/Postal Code
H91 YR71
Country
Ireland
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Evaluating a Digital Intervention for Overactive Bladder
We'll reach out to this number within 24 hrs